Neonatal and Pediatric Clinical Pharmacology, An Issue of Pediatric Clinics

Neonatal and Pediatric Clinical Pharmacology, An Issue of Pediatric Clinics

by Gideon Koren, John N van den Anker, Max J. Coppes

240 pages· 2012· ISBN 9781455747382
About
The need for safe and effective use of medicines in children and WHO's initiative "Make Medicines Child Size" have boosted research and educational activities in the area of pediatric clinical drug research. This issue focuses on both general and specific aspects of neonatal and pediatric clinical pharmacology including ethics, pharmacogenomics, metabolomics, adverse drug reactions, pain medication, pulmonary hypertension and several other hot topics. The editors have been able to find outstanding authors for the different parts on neonatal and pediatric pharmacology.

Discuss Neonatal and Pediatric Clinical Pharmacology, An Issue of Pediatric Clinics with other readers

Join or start a book club for Neonatal and Pediatric Clinical Pharmacology, An Issue of Pediatric Clinics on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Frequently asked questions

How do I join a book club for Neonatal and Pediatric Clinical Pharmacology, An Issue of Pediatric Clinics?

Sign up free on Readfeed, then browse public clubs or start your own club with Neonatal and Pediatric Clinical Pharmacology, An Issue of Pediatric Clinics as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Neonatal and Pediatric Clinical Pharmacology, An Issue of Pediatric Clinics with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Neonatal and Pediatric Clinical Pharmacology, An Issue of Pediatric Clinics with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.